Medical Care

Global Tauopathies Treatment Market Research Report 2025

The global market for Tauopathies Treatment was valued at US$ 887 million in the year 2024 and is projected to reach a revised size of US$ 1566 million by 2031, growing at a CAGR of 8.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tauopathies Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tauopathies Treatment.
The Tauopathies Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tauopathies Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tauopathies Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb Company
Selvita S.A
SK Biopharmaceuticals Co., Ltd.
Chronos Therapeutics Limited
Segment by Type
SEL-141
RDC-5
YM-08
Thiamet-G
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tauopathies Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tauopathies Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 SEL-141
1.2.3 RDC-5
1.2.4 YM-08
1.2.5 Thiamet-G
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tauopathies Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tauopathies Treatment Market Perspective (2020-2031)
2.2 Global Tauopathies Treatment Growth Trends by Region
2.2.1 Global Tauopathies Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tauopathies Treatment Historic Market Size by Region (2020-2025)
2.2.3 Tauopathies Treatment Forecasted Market Size by Region (2026-2031)
2.3 Tauopathies Treatment Market Dynamics
2.3.1 Tauopathies Treatment Industry Trends
2.3.2 Tauopathies Treatment Market Drivers
2.3.3 Tauopathies Treatment Market Challenges
2.3.4 Tauopathies Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tauopathies Treatment Players by Revenue
3.1.1 Global Top Tauopathies Treatment Players by Revenue (2020-2025)
3.1.2 Global Tauopathies Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Tauopathies Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tauopathies Treatment Revenue
3.4 Global Tauopathies Treatment Market Concentration Ratio
3.4.1 Global Tauopathies Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tauopathies Treatment Revenue in 2024
3.5 Global Key Players of Tauopathies Treatment Head office and Area Served
3.6 Global Key Players of Tauopathies Treatment, Product and Application
3.7 Global Key Players of Tauopathies Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tauopathies Treatment Breakdown Data by Type
4.1 Global Tauopathies Treatment Historic Market Size by Type (2020-2025)
4.2 Global Tauopathies Treatment Forecasted Market Size by Type (2026-2031)
5 Tauopathies Treatment Breakdown Data by Application
5.1 Global Tauopathies Treatment Historic Market Size by Application (2020-2025)
5.2 Global Tauopathies Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tauopathies Treatment Market Size (2020-2031)
6.2 North America Tauopathies Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tauopathies Treatment Market Size by Country (2020-2025)
6.4 North America Tauopathies Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tauopathies Treatment Market Size (2020-2031)
7.2 Europe Tauopathies Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tauopathies Treatment Market Size by Country (2020-2025)
7.4 Europe Tauopathies Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tauopathies Treatment Market Size (2020-2031)
8.2 Asia-Pacific Tauopathies Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tauopathies Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Tauopathies Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tauopathies Treatment Market Size (2020-2031)
9.2 Latin America Tauopathies Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tauopathies Treatment Market Size by Country (2020-2025)
9.4 Latin America Tauopathies Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tauopathies Treatment Market Size (2020-2031)
10.2 Middle East & Africa Tauopathies Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tauopathies Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Tauopathies Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Details
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Tauopathies Treatment Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2020-2025)
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Selvita S.A
11.2.1 Selvita S.A Company Details
11.2.2 Selvita S.A Business Overview
11.2.3 Selvita S.A Tauopathies Treatment Introduction
11.2.4 Selvita S.A Revenue in Tauopathies Treatment Business (2020-2025)
11.2.5 Selvita S.A Recent Development
11.3 SK Biopharmaceuticals Co., Ltd.
11.3.1 SK Biopharmaceuticals Co., Ltd. Company Details
11.3.2 SK Biopharmaceuticals Co., Ltd. Business Overview
11.3.3 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Introduction
11.3.4 SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2020-2025)
11.3.5 SK Biopharmaceuticals Co., Ltd. Recent Development
11.4 Chronos Therapeutics Limited
11.4.1 Chronos Therapeutics Limited Company Details
11.4.2 Chronos Therapeutics Limited Business Overview
11.4.3 Chronos Therapeutics Limited Tauopathies Treatment Introduction
11.4.4 Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2020-2025)
11.4.5 Chronos Therapeutics Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tauopathies Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of SEL-141
Table 3. Key Players of RDC-5
Table 4. Key Players of YM-08
Table 5. Key Players of Thiamet-G
Table 6. Key Players of Others
Table 7. Global Tauopathies Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Tauopathies Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Tauopathies Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Tauopathies Treatment Market Share by Region (2020-2025)
Table 11. Global Tauopathies Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Tauopathies Treatment Market Share by Region (2026-2031)
Table 13. Tauopathies Treatment Market Trends
Table 14. Tauopathies Treatment Market Drivers
Table 15. Tauopathies Treatment Market Challenges
Table 16. Tauopathies Treatment Market Restraints
Table 17. Global Tauopathies Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Tauopathies Treatment Market Share by Players (2020-2025)
Table 19. Global Top Tauopathies Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tauopathies Treatment as of 2024)
Table 20. Ranking of Global Top Tauopathies Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Tauopathies Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Tauopathies Treatment, Headquarters and Area Served
Table 23. Global Key Players of Tauopathies Treatment, Product and Application
Table 24. Global Key Players of Tauopathies Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tauopathies Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Tauopathies Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Tauopathies Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Tauopathies Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Tauopathies Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Tauopathies Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global Tauopathies Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Tauopathies Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America Tauopathies Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Tauopathies Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Tauopathies Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Tauopathies Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Tauopathies Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Tauopathies Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Tauopathies Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Tauopathies Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Tauopathies Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Tauopathies Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Tauopathies Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Tauopathies Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Tauopathies Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Tauopathies Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Tauopathies Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. Bristol-Myers Squibb Company Company Details
Table 50. Bristol-Myers Squibb Company Business Overview
Table 51. Bristol-Myers Squibb Company Tauopathies Treatment Product
Table 52. Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2020-2025) & (US$ Million)
Table 53. Bristol-Myers Squibb Company Recent Development
Table 54. Selvita S.A Company Details
Table 55. Selvita S.A Business Overview
Table 56. Selvita S.A Tauopathies Treatment Product
Table 57. Selvita S.A Revenue in Tauopathies Treatment Business (2020-2025) & (US$ Million)
Table 58. Selvita S.A Recent Development
Table 59. SK Biopharmaceuticals Co., Ltd. Company Details
Table 60. SK Biopharmaceuticals Co., Ltd. Business Overview
Table 61. SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Product
Table 62. SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2020-2025) & (US$ Million)
Table 63. SK Biopharmaceuticals Co., Ltd. Recent Development
Table 64. Chronos Therapeutics Limited Company Details
Table 65. Chronos Therapeutics Limited Business Overview
Table 66. Chronos Therapeutics Limited Tauopathies Treatment Product
Table 67. Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2020-2025) & (US$ Million)
Table 68. Chronos Therapeutics Limited Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
Table 72. Authors List of This Report


List of Figures
Figure 1. Tauopathies Treatment Picture
Figure 2. Global Tauopathies Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tauopathies Treatment Market Share by Type: 2024 VS 2031
Figure 4. SEL-141 Features
Figure 5. RDC-5 Features
Figure 6. YM-08 Features
Figure 7. Thiamet-G Features
Figure 8. Others Features
Figure 9. Global Tauopathies Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Tauopathies Treatment Market Share by Application: 2024 VS 2031
Figure 11. Clinic Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Tauopathies Treatment Report Years Considered
Figure 15. Global Tauopathies Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Tauopathies Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Tauopathies Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Tauopathies Treatment Market Share by Players in 2024
Figure 19. Global Top Tauopathies Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tauopathies Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Tauopathies Treatment Revenue in 2024
Figure 21. North America Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Tauopathies Treatment Market Share by Country (2020-2031)
Figure 23. United States Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Tauopathies Treatment Market Share by Country (2020-2031)
Figure 27. Germany Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Tauopathies Treatment Market Share by Region (2020-2031)
Figure 35. China Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Tauopathies Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Tauopathies Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Tauopathies Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Tauopathies Treatment Business (2020-2025)
Figure 51. Selvita S.A Revenue Growth Rate in Tauopathies Treatment Business (2020-2025)
Figure 52. SK Biopharmaceuticals Co., Ltd. Revenue Growth Rate in Tauopathies Treatment Business (2020-2025)
Figure 53. Chronos Therapeutics Limited Revenue Growth Rate in Tauopathies Treatment Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies